See more : Zhuhai Enpower Electric Co.,Ltd. (300681.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of Accolade, Inc. (ACCD) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Accolade, Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- GMO Payment Gateway, Inc. (3769.T) Income Statement Analysis – Financial Results
- Taisei Lamick Co., Ltd. (4994.T) Income Statement Analysis – Financial Results
- WARDWIZARD INNOVATIONS AND MOB (WARDINMOBI.BO) Income Statement Analysis – Financial Results
- medondo holding AG (AMI.DE) Income Statement Analysis – Financial Results
- Terranet AB (TERRNT-B.ST) Income Statement Analysis – Financial Results
Accolade, Inc. (ACCD)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.accolade.com
About Accolade, Inc.
Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|
| Revenue | 414.29M | 363.14M | 310.02M | 170.36M | 132.51M | 94.81M | 76.83M |
| Cost of Revenue | 222.23M | 198.91M | 169.02M | 93.67M | 73.69M | 60.57M | 53.44M |
| Gross Profit | 192.06M | 164.24M | 141.00M | 76.69M | 58.82M | 34.24M | 23.39M |
| Gross Profit Ratio | 46.36% | 45.23% | 45.48% | 45.01% | 44.39% | 36.12% | 30.45% |
| Research & Development | 99.16M | 101.35M | 83.66M | 49.96M | 42.31M | 35.71M | 31.49M |
| General & Administrative | 62.12M | 81.21M | 99.11M | 31.58M | 26.15M | 19.67M | 21.12M |
| Selling & Marketing | 100.07M | 99.11M | 86.77M | 33.71M | 30.05M | 23.46M | 22.26M |
| SG&A | 162.19M | 180.32M | 185.87M | 65.30M | 56.20M | 43.12M | 43.39M |
| Other Expenses | 45.16M | 46.38M | 42.61M | 8.21M | 8.52M | -90.00K | -26.00K |
| Operating Expenses | 307.20M | 328.05M | 312.14M | 123.46M | 107.03M | 88.22M | 82.85M |
| Cost & Expenses | 528.75M | 526.95M | 481.16M | 217.14M | 180.71M | 148.79M | 136.29M |
| Interest Income | 0.00 | 255.00K | 2.91M | 3.72M | 2.93M | 2.37M | 0.00 |
| Interest Expense | 0.00 | 255.00K | 2.91M | 3.72M | 2.93M | 2.37M | 1.80M |
| Depreciation & Amortization | 45.16M | 47.38M | 42.61M | 8.21M | 8.52M | 9.39M | 7.98M |
| EBITDA | -71.19M | -110.35M | -130.92M | -38.71M | -39.80M | -44.68M | -51.51M |
| EBITDA Ratio | -17.18% | 50.19% | -41.50% | -22.72% | -30.03% | -47.12% | -67.04% |
| Operating Income | -114.45M | 135.90M | -171.14M | -46.78M | -48.20M | -53.98M | -59.46M |
| Operating Income Ratio | -27.63% | 37.42% | -55.20% | -27.46% | -36.38% | -56.93% | -77.39% |
| Total Other Income/Expenses | 15.88M | 240.00K | -3.04M | -3.87M | -3.03M | -2.46M | -1.83M |
| Income Before Tax | -98.57M | -463.27M | -128.76M | -50.65M | -51.24M | -56.44M | -61.29M |
| Income Before Tax Ratio | -23.79% | -127.57% | -41.53% | -29.73% | -38.67% | -59.53% | -79.77% |
| Income Tax Expense | 1.24M | -3.62M | -5.64M | 4.00K | 129.00K | 55.00K | 1.77M |
| Net Income | -99.81M | -459.65M | -123.12M | -50.65M | -51.37M | -56.50M | -61.29M |
| Net Income Ratio | -24.09% | -126.58% | -39.71% | -29.73% | -38.76% | -59.59% | -79.77% |
| EPS | -1.33 | -6.45 | -1.93 | -1.72 | -1.05 | -1.63 | -1.77 |
| EPS Diluted | -1.33 | -6.45 | -1.93 | -1.72 | -1.05 | -1.63 | -1.77 |
| Weighted Avg Shares Out | 74.91M | 71.28M | 63.82M | 29.37M | 48.79M | 34.63M | 34.63M |
| Weighted Avg Shares Out (Dil) | 74.91M | 71.28M | 63.82M | 29.37M | 48.79M | 34.63M | 34.63M |
Accolade: A GARP Stock Trading Well Under 1X Revenues
Accolade (ACCD) Upgraded to Buy: Here's Why
Accolade To Present at Upcoming Investor Conferences
Porter Airlines Receives Another Accolade with APEX Four Star Major Airline Rating
Accolade (ACCD) Loses -15.57% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Accolade Welcomes Renalogic to Trusted Partner Ecosystem
Accolade (ACCD) Upgraded to Buy: Here's What You Should Know
Accolade, Inc. (ACCD) Q2 2025 Earnings Call Transcript
Accolade (ACCD) Reports Q2 Loss, Tops Revenue Estimates
Accolade Inc (ACCD) Q2 Earnings: Revenue Hits $106.4M, Beating Estimates; GAAP EPS Loss at $0.30
Source: https://incomestatements.info
Category: Stock Reports